Unlock instant, AI-driven research and patent intelligence for your innovation.

Medicine composition for treating mastopathy hyperplasia and its preparing process

A technology for breast hyperplasia and composition, which is applied in the directions of drug combinations, pharmaceutical formulations, and medical preparations containing active ingredients, and can solve the problems of large side effects, high recurrence rate, and long hormone therapy cycle.

Inactive Publication Date: 2006-07-26
JIANGSU SUZHONG PHARM GRP CO LTD
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, western medicine mainly adopts hormone therapy, but the cycle of hormone therapy is long, the recurrence rate is high, the side effects are large, and it will disturb the balance of hormones in the body

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0101] The preparation of pharmaceutical composition capsule of the present invention

[0102] Take each bulk drug by weight ratio:

[0103] Antlers 8.3g, Polygonum multiflorum 8.3g, Cnidium 8.3g, Moutan bark 8.3g, Radix Paeoniae Rubra 8.3g, Curcuma 8.3g, Kelp 8.3g, Oyster 16.7g.

[0104] Add 10 times the amount of water to soak the antlers for 1 hour, decoct 3 times for 2 hours each time, combine the decoction liquid, concentrate to a relative density of 1.05, and obtain thick paste A. Cortex Moutan was steam distilled, the distilled liquid was collected to 10 times the weight of the medicinal material, refrigerated for 24 hours, and suction filtered to obtain paeonol crystal B. Moutan cortex dregs and water for later use. Add 70% ethanol to the prescription amount of Radix Polygoni Multiflori and Radix Paeoniae Rubra and reflux extraction for 3 times, each time for 1.5 hours, combine the ethanol extracts, and set aside C 1 . Separately take the remaining medicinal materi...

Embodiment 2

[0106] The preparation of pharmaceutical composition granule of the present invention:

[0107] Antlers 8.0g, Polygonum multiflorum 8.0g, Cnidium 8.0g, Moutan bark 8.0g, Radix Paeoniae Rubra 8.0g, Curcuma 8.0g, Kelp 8.0g, Oyster 16.0g.

[0108] Add 10 times the amount of water to soak the antlers for 1 hour, decoct 3 times for 2 hours each time, combine the decoction liquid, concentrate to a relative density of 1.15, and obtain thick paste A. Cortex Moutan was steam distilled, and the distillate was collected to 10 times the weight of the medicinal material, refrigerated for 48 hours, and suction filtered to obtain paeonol crystal B. Moutan cortex dregs and water for later use. Add 70% ethanol to the prescription amount of Radix Polygoni Multiflori and Radix Paeoniae Rubra and extract under reflux for 3 times, each time for 1.5 hours, combine the ethanol extracts, and reserve C1. Separately take the remaining medicinal materials of the prescription and combine the dregs of M...

Embodiment 3

[0110] Antlers 5.3g, Polygonum multiflorum 5.3g, Cnidium 5.3g, Moutan bark 5.3g, Radix Paeoniae Rubra 5.3g, Kelp 5.3g, Oyster 13.7g.

[0111] Soak the antlers with 12 times the amount of water for 1 hour, decoct for 2 hours, and combine the decoction. Concentrate to a relative density of 1.05 to obtain a thick paste A. Cortex Moutan was steam distilled, the distilled liquid was collected to 12 times the amount of medicinal materials, refrigerated for 48 hours, and paeonol crystal B was obtained by suction filtration. Moutan cortex dregs and water for later use. Take the remaining medicinal materials of the prescription and combine the moutan cortex dregs, add 12 times the amount of water, decoct 3 times, 2 hours each time, separate and collect Cnidium volatilization and save it, combine the decoction and concentrate to 1.20, add ethanol for pure precipitation, and make the alcohol The concentration is 60%, refrigerated, filtered, ethanol is recovered under reduced pressure a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A Chinese medicine for treating mastoplasia by interior application is prepared from 8 Chinese-medicinal materials including antler, fleece flower root, tree peony bark, red peony root, etc. Its advantage is high curative effect.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating breast pain and breast lumps caused by mammary gland hyperplasia and a preparation method thereof, in particular to a pharmaceutical composition containing traditional Chinese medicine extracts and a preparation method thereof. Background technique [0002] Hyperplasia of mammary glands belongs to the category of "breast addiction" in traditional Chinese medicine. Physicians of all dynasties have discussed this disease, and most of them regard "treating mammary syndrome without revealing a single breath" ("Compilation of Foreign Syndrome Medical Cases") as the rule of thumb. Soothe the liver and regulate qi as the main method for treatment. Experts believe that mammary gland hyperplasia is closely related to the menstrual cycle. In terms of pathogenesis, the theory of the pituitary-mammary gland-gonadal axis of Western medicine and the theory of liver and kidney deficiency, Chong-ren im...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/71A61K125/00A61K36/704A61K36/234A61K131/00A61K36/02A61K35/56A61K35/32A61P15/14
Inventor 唐仁茂徐柏颐丛旭东林爱琴
Owner JIANGSU SUZHONG PHARM GRP CO LTD